GRATZKE, Christian, MAANEN, Rob van, CHAPPLE, Christopher R., ABRAMS, Paul, HERSCHORN, Sender, ROBINSON, Dudley, RIDDER, Arwin, STOELZEL, Matthias, PAIREDDY, Asha, YOON, Sang Jin, AL-SHUKRI, Salman, RECHBERGER, Tomasz und MUELLER, Elizabeth R., 2023. Long-term safety and efficacy of Mirabegron and Solifenacin in combination compared with monotherapy in patients with overactive bladder: a randomised, multicentre phase 3 study (SYNERGY II). Freiburg: Universität.
Elsevier - Harvard (with titles)Gratzke, C., Maanen, R. van, Chapple, C.R., Abrams, P., Herschorn, S., Robinson, D., Ridder, A., Stoelzel, M., Paireddy, A., Yoon, S.J., Al-Shukri, S., Rechberger, T., Mueller, E.R., 2023. Long-term safety and efficacy of Mirabegron and Solifenacin in combination compared with monotherapy in patients with overactive bladder: a randomised, multicentre phase 3 study (SYNERGY II). Universität, Freiburg. https://doi.org/10.1016/j.eururo.2018.05.005
American Psychological Association 7th editionGratzke, C., Maanen, R. van, Chapple, C. R., Abrams, P., Herschorn, S., Robinson, D., Ridder, A., Stoelzel, M., Paireddy, A., Yoon, S. J., Al-Shukri, S., Rechberger, T., & Mueller, E. R. (ca. 2023). Long-term safety and efficacy of Mirabegron and Solifenacin in combination compared with monotherapy in patients with overactive bladder: a randomised, multicentre phase 3 study (SYNERGY II) [Cd]. Universität. https://doi.org/10.1016/j.eururo.2018.05.005
Springer - Basic (author-date)Gratzke C, Maanen R van, Chapple CR, Abrams P, Herschorn S, Robinson D, Ridder A, Stoelzel M, Paireddy A, Yoon SJ, Al-Shukri S, Rechberger T, Mueller ER (2023) Long-term safety and efficacy of Mirabegron and Solifenacin in combination compared with monotherapy in patients with overactive bladder: a randomised, multicentre phase 3 study (SYNERGY II). Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Gratzke, Christian/ Maanen, Rob van/ Chapple, Christopher R./ Abrams, Paul/ Herschorn, Sender/ Robinson, Dudley/ Ridder, Arwin/ Stoelzel, Matthias/ Paireddy, Asha/ Yoon, Sang Jin/ Al-Shukri, Salman/ Rechberger, Tomasz/ Mueller, Elizabeth R., Long-term safety and efficacy of Mirabegron and Solifenacin in combination compared with monotherapy in patients with overactive bladder: a randomised, multicentre phase 3 study (SYNERGY II), Freiburg 2023.